Learn more

EPIVAX INC

Overview
  • Total Patents
    75
  • GoodIP Patent Rank
    36,766
  • Filing trend
    ⇧ 325.0%
About

EPIVAX INC has a total of 75 patent applications. It increased the IP activity by 325.0%. Its first patent ever was published in 2008. It filed its patents most often in United States, EPO (European Patent Office) and Australia. Its main competitors in its focus markets biotechnology, pharmaceuticals and measurement are HUMAN GENOME SCIENCES INC, HUIYANGTECH USA INC and ALLERGENE LTD.

Patent filings per year

Chart showing EPIVAX INCs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Martin William 56
#2 De Groot Anne 51
#3 Rivera Dan 35
#4 Rivera Daniel S 16
#5 De Groot Anne S 12
#6 Martin William D 12
#7 Rosenberg Amy S 5
#8 William D Martin 2
#9 Anne S De Groot 2
#10 Ato Manabu 2

Latest patents

Publication Filing date Title
AU2018346681A1 Regulatory T cell epitopes
US2018161419A1 Methods for improving the efficacy of vaccine antigens
AU2016203577A1 Regulatory T cell epitopes, compositions and uses thereof
CN107921097A The modification H7 hemagglutinin glycoprotein of influenza A/SHANGHAI/2/2013 H7 sequences
US2018179256A1 Modified H7 Hemagglutinin Glycoprotein of the Influenza A/Shanghai/2/2013 H7 Sequence
AU2014201846A1 Regulatory t cell epitopes, compositions and uses thereof
MX2009008230A Regulatory t cell epitopes, compositions and uses thereof.